Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 9Unknown 4Terminated 4Recruiting 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 18Gastrointestinal 15Gynecologic 10Genitourinary 10Head & Neck 9Thoracic 5CNS 5Tumor-Agnostic 4Plasma cell 2Other solid neoplasm 2Other hematologic neoplasm 2Lymphoid 2Other neoplasm 1Other 1Myeloid 1Endocrine 1Dermatologic 1

Conditions

Multiple Myeloma 2Lung Neoplasms 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Dexamethasone 130Lenalidomide 82daratumumab 60Bortezomib 56carfilzomib 45Calcium Dobesilate 41pomalidomide 37Cyclophosphamide 31isatuximab 26belantamab mafodotin 23Specimen Handling 21Biopsy 21Magnetic Resonance Spectroscopy 18dexamethasone acetate 16dexamethasone 21-phosphate 16ixazomib 15auricularum 15fludarabine 13Melphalan 13iberdomide 11elotuzumab 11selinexor 10fludarabine phosphate 9X-Rays 8talquetamab 7venetoclax 6trametinib 6nirogacestat 6Whole-Body Irradiation 6Thalidomide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Surveys and Questionnaires × Plasma cell × Clear all
NCT05587972 2026-02-23

Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring

Carevive Systems, Inc.

Phase NA Active not recruiting
100 enrolled
BreastGastrointestinalPlasma cellThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Multiple Myeloma

NCT04497961 2025-09-11

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
95 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡